🥇 First rule of investing? Know when to save! Up to 55% off Investing Pro before BLACK FRIDAYCLAIM SALE

Oruka Therapeutics Inc (ORKA)

NASDAQ
Currency in USD
26.680
+1.060(+4.14%)
Closed
After Hours
26.470-0.210(-0.787%)
ORKA Scorecard
Full Analysis
Suffers from weak gross profit margins
Unusual trading volume
Fair Value
Day's Range
25.15027.390
52 wk Range
10.06833.000
Prev. Close
25.62
Open
25.15
Day's Range
25.15-27.39
52 wk Range
10.068-33
Volume
159,013
Average Volume (3m)
73,683
1-Year Change
125.9%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ORKA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
43.167
Upside
+61.795%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

Oruka Therapeutics Company Profile

Oruka Therapeutics, Inc., a biotechnology company, develops novel biologics for the treatment of chronic skin diseases. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23 (IL-23p19); and ORKA-002 that targets interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of psoriasis psoriatic arthritis, and other inflammatory diseases. The company is based in Waltham, Massachusetts.

Compare ORKA to Peers and Sector

Metrics to compare
ORKA
Peers
Sector
Relationship
P/E Ratio
-−3.3x−0.6x
PEG Ratio
-0.270.00
Price/Book
-2.9x2.6x
Price / LTM Sales
-30.2x3.2x
Upside (Analyst Target)
59.3%137.4%44.1%
Fair Value Upside
Unlock1.5%6.2%Unlock

FAQ

What Is the Oruka Therapeutics (ORKA) Stock Price Today?

The Oruka Therapeutics stock price today is 26.68.

What Stock Exchange Does Oruka Therapeutics Trade On?

Oruka Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Oruka Therapeutics?

The stock symbol for Oruka Therapeutics is "ORKA."

Does Oruka Therapeutics Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 64.52%.

What Is the Oruka Therapeutics Market Cap?

As of today, Oruka Therapeutics market cap is 933.76M.

What is Oruka Therapeutics Earnings Per Share?

The Oruka Therapeutics EPS is -5.97.

From a Technical Analysis Perspective, Is ORKA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.